Drug search by name

Abilify Maintena injection and Hyperglycemia/diabetes

Result of checking the interaction of drug Abilify Maintena injection and disease Hyperglycemia/diabetes for safety when used together.

Check result:

Abilify Maintena injection <> Hyperglycemia/diabetes

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Hyperglycemia, in some cases extreme and associated with ketoacidosis or hyperosmolar coma or death, has been reported with the use of atypical antipsychotic agents. Patients with diabetes should be monitored for worsening control of blood glucose when treated with these agents. It is recommended that patients with risk factors for diabetes mellitus starting treatment with atypical antipsychotics should undergo fasting blood glucose testing at the beginning of treatment, and periodically thereafter. Any patient treated with atypical antipsychotics should be monitored for symptoms of hyperglycemia including polydipsia, polyuria, polyphagia, and weakness. Patients who develop symptoms of hyperglycemia during treatment with atypical antipsychotics should undergo fasting blood glucose testing. In some cases, hyperglycemia has resolved when treatment with these agents was discontinued; however, some patients required continuation of anti-diabetic treatment despite discontinuation of the atypical antipsychotic drug.

Abilify Maintena injection

Generic Name: aripiprazole

Brand Name: Abilify Maintena, Aristada, Abilify, Abilify Discmelt, Abilify MyCite, Aristada Initio

Synonyms: Abilify Maintena (injection), Abilify Maintena

What is Abilify Maintena injection?